Evidence map›Paper›PMID 37857823›Full record

ArticleArchives of osteoporosis2023

Risk factors for the comorbidity of osteoporosis/osteopenia and kidney stones: a cross-sectional study.

Zewu Zhu, Minghui Liu, Youjie Zhang, Jian Wu, Meng Gao, Ting Lei, Fang Huang, Hequn Chen, Maolan Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of osteoporosis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Plasma proteome fingerprint in kidney diseases.Frontiers in molecular biosciences · 2024
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Zewu ZhuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Minghui LiuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Youjie ZhangDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jian WuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Meng GaoDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ting LeiDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Fang HuangDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hequn ChenDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Maolan WuDepartment of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan, China. wumaolan@csu.edu.cn.ORCID http://orcid.org/0000-0002-9334-0674
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low femoral neck bone mineral density (BMD) was associated with the increased risk of kidney stones. Low dietary magnesium intake and increased serum alkaline phosphatase were associated with the increased risk of low femoral neck BMD in kidney stone formers. PURPOSE: To evaluate whether low femoral neck bone mineral density (BMD) was associated with a higher risk of kidney stones, and identify risk factors for the comorbidity of osteoporosis/osteopenia and kidney stones.

methodsWe analyzed individuals aged ≥ 20 years from National Health and Nutrition Examination Survey 2007-2020 data. Osteoporosis/osteopenia is defined as any T-score < -1.0 of femoral neck, total femoral, and mean lumbar spine (L1-L4) BMD. Dietary intakes (sodium, potassium, magnesium, calcium, phosphorus, calcium/phosphorus, vitamin D (25OHD2+25OHD3)) and serum parameters (sodium, potassium, calcium, phosphorus, bicarbonate, vitamin D, alkaline phosphatase (ALP)) were screened for identifying risk factors for the comorbidity.

resultsThe prevalence of comorbidity of osteoporosis/osteopenia and kidney stones was 4.82%. Femoral neck BMD T-score was negatively associated with the prevalence of kidney stones (n=11,864). Dietary magnesium intake, serum phosphorus, and bicarbonate were negatively associated with the comorbidity prevalence, and serum ALP was positively associated with the comorbidity prevalence (n=6978). Additionally, there remain significant associations of dietary magnesium intake, serum ALP, and bicarbonate with not only femoral neck BMD T-score (n=11331), but also the prevalence of kidney stones (n=23,111) in general population. Furthermore, dietary magnesium intake was positively correlated to femoral neck BMD T-score in stone formers (SFs), while serum ALP was negatively correlated to femoral neck BMD T-score in SFs (n=1163).

conclusionLow femoral neck BMD was closely associated with an increased risk of kidney stones. Low magnesium intake and increased serum ALP were associated with the increased risk of the comorbidity, as well as indicative of low femoral neck BMD T-score in SFs, which offered a clue to further clarify the mechanism leading to paradoxical calcification of bone resorption and kidney stones, and had the potential to perform personalized diagnostic workup for low BMD in SFs.

Indexed as

Bone Diseases, MetabolicKidney CalculiOsteoporosisAlkaline PhosphataseBicarbonatesBone DensityCalciumComorbidityCross-Sectional StudiesHumansLumbar VertebraeMagnesiumNutrition SurveysPhosphorusPotassiumRisk FactorsAlkaline PhosphataseBicarbonatesCalciumMagnesiumPhosphorusPotassiumSodiumVitamin DAlkaline phosphataseBone mineral densityKidney stonesMagnesium intake

Identifiers

PMID37857823
OpenAlexW4387782476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.